LAVA liquid embolic system is a new type of embolic agent emerging in the field of interventional therapy in recent years. Because of its excellent visualization and diffusibility, LAVA is favored in interventional treatment fields such as arteriovenous malformations and hypervascular tumors. Especially when LAVA-12 can’t go deep into the lesion with the microcatheter, it can diffuse to a deeper part to complete the embolization, which is better than the diluted embolic agent prepared by the doctor himself, and provides clinicians with more high-quality treatment options. The purpose of this article is to discuss in detail the excellent properties of LAVA in terms of development, dispersion and hand feeling.
First of all, LAVA has excellent visibility. The Lava is mainly composed of a mixture of DMSO, EVOH and tantalum powder, which has a very good imaging effect on vascular malformations, hypervascular tumors and other lesions. Compared with traditional embolic agents, the LAVA liquid embolization system has a higher degree of enhancement, and can more clearly display the branches and bifurcations of blood vessels, and each branch can be clearly defined. During the imaging process, because the imaging site is very clear, it is helpful for doctors to perform more precise operations on the lesion, thus improving the safety and accuracy of the operation.
Secondly, LAVA has excellent dispersibility. LAVA liquid embolic agent has a high viscosity, which can well fill the deformity and funnel part found in angiography, and can effectively embolize the blood supply of abnormal blood vessels. LAVA-12 liquid embolization system has outstanding performance in embolizing small blood vessels, and can be further diffused to reach a farther range. When lesions are deep in blood vessels or embolized microvessels, LAVA-12 can be well diffused to deeper parts, thereby reducing the risk of lesion recurrence. In contrast, the particles used in traditional embolic agents are larger in size and tend to clog blood vessels, thus causing damage to normal tissue.
Finally, LAVA liquid embolic agent is outstanding in terms of feel. Since LAVA liquid embolic agent uses tantalum powder that is finer than traditional embolic agents, it feels less resistance when pushed, and can better adapt to the preference of the surgeon, thereby improving the smoothness of the operation.
In conclusion, LAVA liquid embolization system has excellent visualization, diffusibility, and hand feeling, especially when embolizing microvessels and combined embolization of DAVF, it has more advantages than traditional embolization agents. In the future, we believe that the LAVA liquid embolization system will definitely play a greater role in clinical applications and bring better treatment options to patients.
